glp-1 drugs for obesity Comparing Ozempic, Wegovy and Other The GLP-1 Access Gap: Mapping
Description
Current Opinion in Pediatrics , 36(5), 542-546

Obes Med

2024;20(1):e130423215752

Foundayo produced 12.4% at the highest dose over 72 weeks

These numbers are unprecedented for any medication

[DOI] [PubMed] [Google Scholar] 12.Hansell CE, et al
